Citation: D. Aharony, PHARMACOLOGY OF LEUKOTRIENE RECEPTOR ANTAGONISTS, American journal of respiratory and critical care medicine, 157(6), 1998, pp. 214-219
Authors:
JACOBS RT
SHENVI AB
MAUGER RC
ULATOWSKI TG
AHARONY D
BUCKNER CK
Citation: Rt. Jacobs et al., 4-ALKYLPIPERIDINES RELATED TO SR48968 - POTENT ANTAGONISTS OF THE NEUROKININ-2 (NK2) RECEPTOR, Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1935-1940
Authors:
AHARONY D
BUCKNER CK
ELLIS JL
GHANEKAR SV
GRAHAM A
KAYS JS
LITTLE J
MEEKER S
MILLER SC
UNDEM BJ
WALDRON IR
Citation: D. Aharony et al., PHARMACOLOGICAL CHARACTERIZATION OF NOVEL NONPEPTIDE NEUROKININ-A (NKA) ANTAGONISTS THAT DEMONSTRATE SPECIES SELECTIVITY, The FASEB journal, 10(3), 1996, pp. 934-934
Authors:
AHARONY D
LITTLE J
THOMAS C
POWELL S
DOWNEYJONES M
GRAHAM A
Citation: D. Aharony et al., ISOLATION AND CHARACTERIZATION OF NEUROKININ-A RECEPTOR CDNAS FROM GUINEA-PIG LUNG AND RABBIT PULMONARY-ARTERY (VOL 14, PG 399, 1994), Journal of receptor and signal transduction research, 15(7-8), 1995, pp. 951-952
Authors:
JACOBS RT
MAUGER RC
ULATOWSKI TG
AHARONY D
BUCKNER CK
Citation: Rt. Jacobs et al., SUBSTITUTED 2,4-DIAMINOQUINAZOLINES AND 2,4-DIAMINO-8-ALKYLPURINES ASANTAGONISTS OF THE NEUROKININ-2 (NK2) RECEPTOR, Bioorganic & medicinal chemistry letters, 5(23), 1995, pp. 2879-2884
Authors:
AHARONY D
BUCKNER CK
ELLIS JL
GHANEKAR SV
GRAHAM A
KAYS JS
LITTLE J
MEEKER S
MILLER SC
UNDEM BJ
WALDRON IR
Citation: D. Aharony et al., PHARMACOLOGICAL CHARACTERIZATION OF A NEW CLASS OF NONPEPTIDE NEUROKININ A ANTAGONISTS THAT DEMONSTRATE SPECIES SELECTIVITY, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1216-1221
Authors:
AHARONY D
LITTLE J
THOMAS C
POWELL S
DOWNEYJONES M
GRAHAM A
Citation: D. Aharony et al., ISOLATION AND CHARACTERIZATION OF NEUROKININ-A RECEPTOR CDNAS FROM GUINEA-PIG LUNG AND RABBIT PULMONARY-ARTERY, Journal of receptor research, 14(6-8), 1994, pp. 399-421
Authors:
AHARONY D
LITTLE J
THOMAS C
POWELL S
BERRY D
GRAHAM A
Citation: D. Aharony et al., ISOLATION AND PHARMACOLOGICAL CHARACTERIZATION OF A HAMSTER URINARY-BLADDER NEUROKININ-A RECEPTOR CDNA, Molecular pharmacology, 45(1), 1994, pp. 9-19
Authors:
JACOBS RT
BERNSTEIN PR
CRONK LA
VACEK EP
NEWCOMB LF
AHARONY D
BUCKNER CK
KUSNER EJ
Citation: Rt. Jacobs et al., SYNTHESIS, STRUCTURE-ACTIVITY-RELATIONSHIPS, AND PHARMACOLOGICAL EVALUATION OF A SERIES OF FLUORINATED 3-BENZYL-5-INDOLECARBOXAMIDES - IDENTIFICATION OF ]-3-METHOXY-N-[(2-METHYLPHENYL)SULFONYL]BENZAMIDE, A POTENT, ORALLY-ACTIVE ANTAGONIST OF LEUKOTRIENES D(4) AND E(4), Journal of medicinal chemistry, 37(9), 1994, pp. 1282-1297
Authors:
AHARONY D
LITTLE J
POWELL S
HOPKINS B
BUNDELL KR
MCPHEAT WL
GORDON RD
HASSALL G
HOCKNEY R
GRIFFIN R
GRAHAM A
Citation: D. Aharony et al., PHARMACOLOGICAL CHARACTERIZATION OF CLONED HUMAN NK-2 (NEUROKININ-A) RECEPTOR EXPRESSED IN A BACULOVIRUS SF-21 INSECT-CELL SYSTEM/, Molecular pharmacology, 44(2), 1993, pp. 356-363
Authors:
FALCONE RC
HUBBS SJ
VANDERLOO JD
PROSSER JC
LITTLE J
GOMES B
AHARONY D
KRELL RD
Citation: Rc. Falcone et al., CHARACTERIZATION OF BRADYKININ RECEPTORS IN GUINEA-PIG GALL-BLADDER, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1291-1299